Bausch + Lomb Bausch + Lomb is a company that develops, manufactures, and markets healthcare products. | Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. | Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | Stratpharma Stratpharma is a company specializing in the development and commercialization of medical devices for dermatology, plastic surgery, burns, wounds, and scar management. | ||
Founding Date | Founding Date 1853 | Founding Date 1886 | Founding Date 1948 | Founding Date 1945 | Founding Date 2005 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Vaughan, CA HQ Buenos Aires, AR Vienna, AT Minsk, BY Aalst, BE Porto Alegre, BR São Paulo, BR see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Ultimo, AU Wien, AT Minsk, BY Beerse, BE see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more | Locations Geneva, CH HQ Macquarie Park, AU Wien, AT Mechelen, BE Mississauga, CA Beijing, CN Praha, CZ see more | Locations Basel, CH HQ |
Employees | Employees 13,0002% decrease | Employees 152,7008% increase | Employees 17,658 | Employees 25,000 | Employees 1201% increase |
Valuation ($) | Valuation ($) 6.8 b | Valuation ($) 396.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $4.1b (FY, 2023) | Revenue (est.) $85.2b (FY, 2023) | Revenue (est.) $16.1b (FY, 2019) | Revenue (est.) $9.5b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $26.6b (FY, 2023) | Cost of goods $2.5b (FY, 2019) | Cost of goods $3.1b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $58.6b (FY, 2023) | Gross profit $13.6b (FY, 2019) | Gross profit $6.5b (FY, 2023) | Gross profit N/A |
Net income | Net income ($248m) (FY, 2023) | Net income $35.2b (FY, 2023) | Net income ($5.1b) (FY, 2019) | Net income $974m (FY, 2023) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 100 (Q1, 2020) | Countries 60 (Sep, 2022) | Countries N/A |
Countries (Customers) | Countries (Customers) 100 (FY, 2022) | Countries (Customers) N/A | Countries (Customers) N/A | Countries (Customers) 140 (Sep, 2022) | Countries (Customers) N/A |
Facilities Leased | Facilities Leased 3 (FY, 2022) | Facilities Leased N/A | Facilities Leased 11 (FY, 2019) | Facilities Leased N/A | Facilities Leased N/A |
Facilities Owned | Facilities Owned 11 (FY, 2022) | Facilities Owned N/A | Facilities Owned 10 (FY, 2019) | Facilities Owned N/A | Facilities Owned N/A |